The story lands roughly two years after OpenAI CEO Sam Altman publicly predicted that AI would eventually enable a single person to build a billion-dollar company. Medvi, a telehealth provider specializing in GLP-1 medications, exemplifies this vision. Founded by Matthew Gallagher in September 2024, Medvi has rapidly transformed the healthcare landscape, achieving remarkable sales figures and customer growth.
In 2025, Medvi reported sales of $401 million, and projections indicate that this figure could soar to $1.8 billion in 2026. Gallagher’s innovative approach, which involved an initial investment of just $20,000 and the integration of over a dozen AI tools, has proven to be a game changer. By the end of 2025, Medvi had amassed 250,000 customers, demonstrating the increasing demand for telehealth services.
Gallagher’s brother, Elliot, serves as the company’s sole employee, highlighting the ultra-lean operational model that has become possible through advancements in technology. The company’s net profit margin stood at an impressive 16.2% in 2025, a testament to its efficient business model.
In February 2026, Medvi launched a men’s health line, which quickly gained traction, reaching 50,000 customers within its first month. This rapid expansion underscores the effectiveness of Gallagher’s strategy and the growing acceptance of telehealth solutions.
“Growth was insane,” Gallagher remarked, reflecting on the company’s trajectory. Industry observers have noted that Medvi’s success is not just an anomaly but a reflection of a broader trend in the healthcare sector. Jon Lensing, an industry analyst, stated, “Matthew’s native tongue seems to be A.I.,” emphasizing Gallagher’s adept use of technology to drive growth.
Fortune magazine highlighted Medvi as “proof that AI is enabling ultra-lean, hyper-scalable companies,” further solidifying its status as a leader in the telehealth space. The integration of AI tools like ChatGPT, Claude, and Grok has allowed Medvi to streamline operations and enhance customer engagement.
As the telehealth market continues to evolve, experts predict that Medvi will play a pivotal role in shaping its future. With the healthcare industry increasingly leaning towards digital solutions, the demand for services like those offered by Medvi is expected to rise.
Looking ahead, the company is well-positioned to capitalize on the growing trend of telehealth, potentially setting new benchmarks for success in the industry. As Gallagher continues to innovate, the implications of Medvi’s journey will likely resonate throughout the healthcare landscape for years to come.